var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; googletag.cmd.push(function() { googletag.pubads().disableInitialLoad(); });
device = device.default;
//this function refreshes [adhesion] ad slot every 60 second and makes prebid bid on it every 60 seconds // Set timer to refresh slot every 60 seconds function setIntervalMobile() { if (!device.mobile()) return if (adhesion) setInterval(function(){ googletag.pubads().refresh([adhesion]); }, 60000); } if(device.desktop()) { googletag.cmd.push(function() { leaderboard_top = googletag.defineSlot('/22018898626/LC_Article_detail_page', [468, 60], 'div-gpt-ad-1591620860846-0').setTargeting('pos', ['1']).setTargeting('div_id', ['leaderboard_top']).addService(googletag.pubads()); googletag.pubads().collapseEmptyDivs(); googletag.enableServices(); }); } else if(device.tablet()) { googletag.cmd.push(function() { leaderboard_top = googletag.defineSlot('/22018898626/LC_Article_detail_page', [320, 50], 'div-gpt-ad-1591620860846-0').setTargeting('pos', ['1']).setTargeting('div_id', ['leaderboard_top']).addService(googletag.pubads()); googletag.pubads().collapseEmptyDivs(); googletag.enableServices(); }); } else if(device.mobile()) { googletag.cmd.push(function() { leaderboard_top = googletag.defineSlot('/22018898626/LC_Article_detail_page', [320, 50], 'div-gpt-ad-1591620860846-0').setTargeting('pos', ['1']).setTargeting('div_id', ['leaderboard_top']).addService(googletag.pubads()); googletag.pubads().collapseEmptyDivs(); googletag.enableServices(); }); } googletag.cmd.push(function() { // Enable lazy loading with... googletag.pubads().enableLazyLoad({ // Fetch slots within 5 viewports. // fetchMarginPercent: 500, fetchMarginPercent: 100, // Render slots within 2 viewports. // renderMarginPercent: 200, renderMarginPercent: 100, // Double the above values on mobile, where viewports are smaller // and users tend to scroll faster. mobileScaling: 2.0 }); });
×

Joseph J. LaRosa, Regeneron Pharmaceuticals Inc.

( 50 votes, average: 3.9 out of 5)
What do you think about this article? Rate it using the stars above and let us know what you think in the comments below.
In his new role, LaRosa will manage all of Regeneron's legal matters, ranging from general corporate legal matters to intellectual property and corporate compliance. LaRosa will report to the company's President and Chief Executive Officer, Leonard S. Schleifer, MD, Ph.D.

Prior to accepting the position with Regeneron, LaRosa was the Senior Vice President, General Counsel, and Secretary at Nycomed US Inc., a subsidiary of Nycomed. The company operates two US divisions that concentrate on specialty pharmaceuticals in dermatology.


LaRosa served as the first global chief compliance officer at Avon Products, Inc. from 2009 to 2010.

He also worked for the Schering-Plough Corporation for more than 15 years. During his tenure with the company, he served in a number of senior legal roles, most recently as the Vice President of Legal Affairs and as a member of the Operations Management Team. He has experienced in handling a variety of crucial legal duties including international, US health care and managed market, marketing and sales, commercial law, mergers and acquisitions, and licensing.

LaRosa earned both his JD and undergraduate degrees from New York University. His undergraduate studies were focused on Political Science and Psychology.

''We are extremely pleased to have recruited a seasoned corporate attorney with deep senior-level pharmaceutical experience to lead this important function. Joe's track record managing a variety of key legal functions at Schering-Plough and Nycomed will be directly relevant as Regeneron, which now employs more than 1,600 people, continues to build its product portfolio and the capabilities of a fully integrated pharmaceutical company,'' said Schleifer in response to LaRosa's acceptance of the position.

Regeneron is a New York City area, fully-integrated biopharmaceutical company that creates, develops, produces, and markets medications to treat a number of serious medical issues.

Avon Products, Inc.

    


Featured Testimonials

LawCrossing has a good combination of small and large firms. That's something that I haven't seen in other sources.
Karina Y.


Facts

LawCrossing Fact #73: Users who take advantage of the “My Hotlist” feature will find jobs more easily because they will be able to organize and save their favorite jobs instead of wasting time trying to hunt them down later. The “My Hotlist” feature gives them time to think, compare, and make a valuable decision.

 
Let's Do It!
Email:

Only LawCrossing consolidates every job it can find in the legal industry and puts all of the job listings it locates in one place.

  • We have more than 25 times as many legal jobs as any other job board.
  • We list jobs you will not find elsewhere that are hidden in small regional publications and employer websites.
  • We collect jobs from more than 250,000 websites and post them on our site.
  • Increase your chances of being seen! Employers on public job boards get flooded with applications. Our private job boards ensure that only members can apply to our job postings.

Success Stories

LawCrossing has the most listings of any job board I have used. It's actually a great site. The website had a lot of detail. It’s nice that you don't have to go through a recruiter if you don't want to. You can actually contact the law firm directly for the positions listed. LawCrossing had a ton of great features.
  • Brian McMillan San Francisco, CA

Everyone Loves LawCrossing

I came back to LawCrossing to search through the listings in my new job search because I had been able to get my last 2 jobs through using the site. I love the search capacity and filters. This is a very valuable service.
  • Jennifer Guidea Bloomfield, NJ
+ Read More Success Stories
  • All we do is research jobs
  • Our team of researchers, programmers, and analysts find you jobs from over 50,000 career pages and other sources
  • Our members get more interviews and jobs than people who use "public job boards"